Showing results (301-310 of 327) with videos related to

Sort By:
Pageof 33
Psychological Medicine|May 2, 2023
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control studyEdoardo Spinazzola, Diego Quattrone, Victoria Rodriguez, et al.
Psychological Medicine|March 19, 2020
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control studyDiego Quattrone, Laura Ferraro, Giada Tripoli, et al.
Schizophrenia Bulletin|September 12, 2019
Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI StudyLotta-Katrin Pries, Agustin Lage-Castellanos, Philippe Delespaul, et al.
Frontiers in Psychiatry|October 15, 2019
White Noise Speech Illusions: A Trait-Dependent Risk Marker for Psychotic Disorder?Elaine Schepers, Richel Lousberg, Sinan Guloksuz, et al.
Translational Psychiatry|August 11, 2021
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI studyDiego Quattrone, Ulrich Reininghaus, Alex L Richards, et al.
Psychiatry Research|April 4, 2023
Examining the association between exposome score for schizophrenia and cognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI studyLaura Fusar-Poli, Thanavadee Prachason, Gamze Erzin, et al.
Psychological Medicine|October 13, 2020
A replication study of JTC bias, genetic liability for psychosis and delusional ideationCécile Henquet, Jim van Os, Lotta K Pries, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 19, 2021
Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI studyGamze Erzin, Lotta-Katrin Pries, Jim van Os, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 2, 2022
The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI studyLaura Fusar-Poli, Lotta-Katrin Pries, Jim van Os, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 18, 2021
Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI studyLaura Fusar-Poli, Lotta-Katrin Pries, Jim van Os, et al.
Pageof 33